ADAR1 Capital Management »

Embrace Change Acquisitn Cor shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Embrace Change Acquisitn Cor (EMCGW) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Embrace Change Acquisitn Cor

Tip: Access up to 7 years of quarterly data

All positions including Embrace Change Acquisitn Cor held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Embrace Change Acquisitn Cor by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $234 18k 0.01

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Roivant Sciences SHS (ROIV)
Cytokinetics Com New (CYTK)
Arbutus Biopharma (ABUS)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Cerevel Therapeutics Hldng I (CERE)
Mirati Therapeutics
Merck & Co (MRK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Immunovant (IMVT)
Viking Therapeutics (VKTX)
Protagonist Therapeutics (PTGX)

View all positions for ADAR1 Capital Management

Top funds holding Embrace Change Acquisitn Cor

Polar Securities
Wolverine Asset Management
Context Capital Management
Hudson Bay Capital Management
Weiss Asset Management LP[1
CNH Partners
Cowen And Company
Walleye Trading Advisors
Schechter Investment Advisors
D. E. Shaw & Co
Cable Car Capital
Walleye Trading
Spartan Fund Management
Berkley W R
ADAR1 Capital Management

View all funds holding Embrace Change Acquisitn Cor